Glow 60 mg
All Products

Glow 60 mg

Triple Peptide Blend

  • Substance:
     - BPC-157 10 mg
     - TB-500 10 mg
     - GHK-Cu 40mg
  • Strength: 60 mg total blend/vial
  • Form: Lyophilized powder
  • Packaging: 2 mL glass vial
  • Manufacturer: Dragon Pharma, Europe
Authentic Dragon Pharma Product
Free Shipping on Orders $800+
Discreet Packaging Guaranteed
$120.00 $200.00
Warehouse :
International
U.S. Domestic
You will save $80.00

Dragon Pharma Glow

Glow 60 mg represents a cutting-edge research formulation that synergistically combines three of the most powerful regenerative peptides into a single, comprehensive blend: BPC-157 (10 mg), TB-500 (10 mg), and GHK-Cu (40 mg). This meticulously engineered 60 mg total peptide complex is specifically designed for research into comprehensive tissue repair, skin rejuvenation, and systemic anti-aging. Each component brings unique mechanisms that complement and amplify the others: BPC-157 provides exceptional healing and anti-inflammatory properties, TB-500 enhances cellular migration and angiogenesis, while GHK-Cu stimulates collagen/elastin synthesis and provides antioxidant protection. Together, they create a multi-targeted research tool that addresses tissue repair from cellular to systemic levels.

For bodybuilders, athletes, and anti-aging researchers in the USA, Dragon Pharma Glow 60 mg offers unprecedented convenience and synergistic potential for studying comprehensive recovery and rejuvenation. The blend is particularly valuable for research on skin quality improvement, scar reduction, connective tissue repair, joint health, and overall tissue resilience. The 60 mg total concentration—with its distinctive blue tint from the GHK-Cu component—provides ample material for extended research protocols. This pre-formulated blend eliminates the need for researchers to source, measure, and combine three separate peptides, ensuring consistent ratios and reducing potential errors. Manufactured by Dragon Pharma under strict pharmaceutical-grade conditions in certified European facilities, each vial guarantees precise 1:1:4 ratio blending and maximum purity for reliable experimental outcomes across dermatological, orthopedic, and regenerative medicine research applications.

Key Benefits:

  • Synergistic Triple-Action Formula: Combines BPC-157 (healing), TB-500 (cell migration), and GHK-Cu (collagen synthesis) for comprehensive tissue repair research.
  • Advanced Skin Rejuvenation Research: Specifically formulated for studies on skin elasticity, wrinkle reduction, scar improvement, and overall dermatological health.
  • Enhanced Connective Tissue Repair: Ideal for research on tendon/ligament healing, joint recovery, and musculoskeletal injury models.
  • Convenient Pre-Mixed Blend: Eliminates measurement errors and ensures consistent 1:1:4 peptide ratio (BPC-157:TB-500:GHK-Cu) across all research protocols.
  • High-Concentration Research Formula: 60 mg total peptide content provides substantial material for extended topical, subcutaneous, and combination study designs.

Each 2 mL vial contains a precisely blended 60 mg peptide complex: 10 mg BPC-157, 10 mg TB-500, and 40 mg GHK-Cu as a sterile lyophilized powder with characteristic blue coloration from the copper peptide, manufactured under Dragon Pharma's exacting pharmaceutical-grade standards.

Product Specifications

Product Name Glow 60 mg
Manufacturer Dragon Pharma
Substance BPC-157 + TB-500 + GHK-Cu Blend
Packaging 2 mL glass vial, lyophilized blue-tinged powder
Lab Test Result Precise 1:1:4 ratio blend (≥98% purity each component)
Half-Life Varies by component: BPC-157 (hours), TB-500 (~1-2 weeks), GHK-Cu (~2 hours)
Recommended Cycle Research cycles: 4-8 weeks for acute injury/skin studies, 8-12 weeks for systemic anti-aging research.
Form Lyophilized (freeze-dried) powder blend for reconstitution
Aromatization Not applicable (non-hormonal peptide blend)
Dosage (Research Models) Studied with various protocols: daily subcutaneous, topical application, or localized near injury/skin areas.

Usage Guidelines

Research Application Only: This information summarizes scientific literature for educational context. Dragon Pharma Glow 60 mg is a research chemical for laboratory investigation, not for human consumption.

In experimental settings, the Glow blend is reconstituted with bacteriostatic water. The resulting solution will have a blue tint from the GHK-Cu component, confirming proper peptide blending. Research administration routes include: 1) Subcutaneous injection (for systemic effects or localized near areas of interest), 2) Topical application (mixed into creams, gels, or serums for skin studies), and 3) Occasionally intramuscular near injury sites. The varied half-lives of the components (BPC-157: hours; TB-500: weeks; GHK-Cu: hours) create both immediate and sustained effects, making daily or every-other-day administration common in research protocols. For skin-focused studies, combination approaches (systemic + topical) often yield the most comprehensive results.

  • Skin Rejuvenation & Anti-Aging Research (6-8 weeks): Daily topical ± subcutaneous administration to study effects on collagen synthesis, skin elasticity, wrinkle reduction, and overall dermatological parameters.
  • Comprehensive Tissue Repair Protocol (8-12 weeks): Extended cycle combining subcutaneous and localized administration for research on injury recovery, scar reduction, and connective tissue health.

Post Cycle Therapy (PCT):

As a non-hormonal peptide blend, Glow does not affect the HPTA, so traditional PCT with SERMs like Clomid is not applicable. The research focus is maintaining tissue health after cessation. Protocols might transition to maintenance dosing of individual components or switch to supportive compounds like SS-31 for mitochondrial health. For ongoing skin research, topical antioxidants or lower-dose GHK-Cu 10 mg could be incorporated into follow-up studies.

Synergistic Research Combinations:

The Glow blend itself is synergistic, but can be studied alongside other compounds for enhanced effects. For maximal recovery research, combining with growth hormone secretagogues like Ipamorelin or CJC No DAC/Ipamorelin could amplify tissue repair. For anti-aging studies, pairing with Epitalon (telomere support) creates comprehensive longevity research. In athletic models, adding IGF-1 LR3 may enhance muscle repair synergy. For joint-specific research, combining with Deca 300 (Nandrolone) could study connective tissue support in anabolic environments.

Storage Instructions

Proper storage is critical to maintain the stability of this advanced peptide blend.

  • Unreconstituted Powder: Store the sealed vial in a freezer at -20°C (-4°F) or colder for long-term stability. The lyophilized blend remains stable for up to 24 months under these conditions. Protect from light (which can fade the blue color) and moisture, and avoid repeated freeze-thaw cycles.
  • After Reconstitution: Once reconstituted with bacteriostatic water, the blue-tinged solution must be refrigerated immediately at 2°C to 8°C (36°F to 46°F). The reconstituted blend is typically stable for research use for 4-6 weeks when refrigerated and protected from light. For optimal results, use within 30 days. Never freeze the liquid solution.
  • Special Considerations for Blended Research: Due to the different stability profiles of the three peptides, it's recommended to use reconstituted material within 30 days for consistent research outcomes. The blue color indicates proper GHK-Cu integrity—fading may suggest degradation of this component.

What does the glow peptide do?

The Glow peptide blend combines three research compounds: BPC-157 (promotes healing and reduces inflammation), TB-500 (enhances cell migration and tissue repair), and GHK-Cu (stimulates collagen/elastin synthesis and provides antioxidant protection). Together, they're studied for comprehensive effects on skin rejuvenation, scar reduction, connective tissue repair, wound healing, and overall tissue health and resilience in aging or injury models.

Where to inject the glow peptide?

Research Use Only: In preclinical studies, administration depends on research goals. For systemic effects, subcutaneous injection in abdominal or thigh areas is common. For localized skin or tissue research, subcutaneous injection near the area of interest (e.g., facial area for skin studies, near joints for connective tissue research) may be used. Topical application (mixed into creams) is also studied for dermatological research. The 60 mg concentration provides flexibility for various administration routes in controlled studies.

What is the ideal research protocol for the Glow blend?

Research protocols vary by objective: For skin studies, daily topical application ± subcutaneous administration for 6-8 weeks is common. For injury/tissue repair, daily subcutaneous injection for 4-8 weeks. For systemic anti-aging research, 8-12 week protocols with every-other-day administration. The blend's components have different half-lives: BPC-157/GHK-Cu require frequent dosing; TB-500 provides longer-lasting effects. Many studies use combination approaches (topical + subcutaneous) for comprehensive effects.

Can the Glow blend be used with other peptides?

Yes, in research settings, the Glow blend is often studied alongside other compounds for enhanced effects. It pairs well with growth hormone secretagogues (like Ipamorelin or CJC-1295) for amplified tissue repair, with Epitalon for comprehensive anti-aging studies, or with individual components at different ratios for specific research objectives. The 60 mg concentration allows for flexible combination research designs while maintaining the core synergistic triad.

Why choose Dragon Pharma's Glow blend over individual peptides?

Dragon Pharma's Glow 60 mg offers significant research advantages:

  1. Guaranteed precise 1:1:4 blending ratio (eliminating measurement errors);
  2. Cost-effective compared to purchasing three separate peptides;
  3. Consistent quality across batches;
  4. Convenience for researchers;
  5. Synergistic formulation based on complementary mechanisms. The blue color confirms proper GHK-Cu copper binding, and third-party testing verifies each component's purity and the correct blend ratio.
No customer reviews yet.

Log in to share your experience with this product.

Related Products
Domestic & International
-40% OFF
AOD 9604 5 mg
Dragon Pharma, Europe

Growth Hormone Fragment 176-191 Peptide

  • Substance: AOD 9604 (hGH 176-191)
  • Strength: 5 mg/vial
  • Form: Lyophilized powder
  • Packaging: 2 mL glass vial
  • Manufacturer: Dragon Pharma, Europe
Authentic Dragon Pharma Product
Free Shipping on Orders $800+
Discreet Packaging Guaranteed
$42.00 $70.00
You will save $28.00
Domestic & International
NEW
-40% OFF
Klow 80 mg
Dragon Pharma, Europe

Comprehensive Healing & Recovery Peptide Blend

  • Substances:
     - BPC-157 10 mg
     - TB-500 10 mg
     - KPV 10 mg
     - GHK-Cu 50 mg
  • Strength: 80 mg total per vial
  • Form: Lyophilized powder blend
  • Packaging: 2 mL sterile vial
  • Manufacturer: Dragon Pharma, Europe
Authentic Dragon Pharma Product
Free Shipping on Orders $800+
Discreet Packaging Guaranteed
$120.00 $200.00
You will save $80.00

Add to Cart - Product(s)

Close Button
Empty

Total Cost: